Lumere to host event June 7–8 in Chicago
Chicago (June 5, 2018) – As the healthcare industry shifts toward a focus on value-based care, hospitals and health systems must continue to innovate and collaborate with new partners and players to maintain a competitive advantage.
On June 7–8 in Chicago, Lumere, a leading provider of evidence-based analytics and expert guidance to reduce unwarranted clinical variation, will host Frontiers 2018: The Way Forward, its second annual forum for healthcare leaders. During this two-day event, hospital executives will join innovators from other industries to discuss new strategies for finding success in a value-based world.
“We take seriously our responsibility to help ensure our clients have the tools and resources necessary to address their most pressing challenges,” said Lumere CEO and Co-Founder Hani Elias, JD, MPH. “At Frontiers 2018, clinical and operational leaders will have the opportunity to interact with thought leaders from organizations that either have deep expertise or are themselves actively involved in changing the way healthcare operates.”
The event will include a mix of lectures and guided conversations around a range of topics, such as artificial intelligence, changes in payer models, value-based contracting and variability in care outcomes. Presenters will include:
- Sachin Gupta, Executive Director – Network Strategy and Value-Based Care, Aetna
- Joshua Kellar, PhD, Partner and Managing Director, The Boston Consulting Group
- Charles Moran, Head of Healthcare Services, Amazon
- Vinay Seth Mohta, Managing Director, Manifold
- Elina Onitskansky, Associate Partner, McKinsey & Company
- Paul Weintraub, Director, Navigant
Additionally, Lumere Chief Medical Officer John Cherf, MD, MPH, MBA, along with physician advisors Julie Schulz, MD, MPH, and Scott A. Falk, MD, will provide attendees with an exclusive first look at Physician Perceptions and Practices 2018, a new study analyzing responses from 276 physicians to a survey about the factors of physician alignment models impacting costs and outcomes.
“Physicians are key stakeholders in the success of value-based care because they control the selection of the drugs and devices used to treat patients,” Dr. Cherf said. “As a result, hospital executives need to forge deeper partnerships with physicians to address cost and quality of care. The insights we uncovered will in this study help us better understand how alignment, cost, variation and evidence all impact the decision-making process.”
Lumere is at the forefront of clinical decision making for drugs and devices, offering evidence-based solutions and services for all providers that improve care and reduce cost across the patient journey. For more information, visit lumere.com, find us on LinkedIn, follow @LumereHQ on Twitter and like us on Facebook.